Jacobi Capital Management’s Genomic Health, Inc. GHDX Stock Holding History

Jacobi Capital Management’s Portfolio GHDX Stock Details GHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-100	Closed	-$7K	–	1127
2019 Q3	$7K	Hold	100	–	–	﹤0.01%	799
2019 Q2	$6K	Hold	100	–	–	﹤0.01%	828
2019 Q1	$7K	Hold	100	–	–	﹤0.01%	752
2018 Q4	$6K	Hold	100	–	–	﹤0.01%	744
2018 Q3	$7K	Hold	100	–	–	﹤0.01%	759
2018 Q2	$5K	Hold	100	–	–	﹤0.01%	840
2018 Q1	$3K	Hold	100	–	–	﹤0.01%	881
2017 Q4	$4K	Hold	100	–	–	﹤0.01%	815
2017 Q3	$3K	Hold	100	–	–	﹤0.01%	821
2017 Q2	$3K	Hold	100	–	–	﹤0.01%	741
2017 Q1	$3K	Hold	100	–	–	﹤0.01%	613
2016 Q4	$3K	Hold	100	–	–	﹤0.01%	551
2016 Q3	$3K	Hold	100	–	–	﹤0.01%	623
2016 Q2	$3K	Buy	+100	New	+$2.66K	﹤0.01%	619

Jacobi Capital Management's GHDX Position: Q4 2019 in Review

Jacobi Capital Management sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 100 shares — an estimated $7K sold.

Jacobi Capital Management first reported a position in GHDX in Q2 2016 and held it in 14 quarters. The position peaked at $7K in Q3 2019. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.

Jacobi Capital Management reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
Jacobi Capital Management sold 100 Genomic Health, Inc. shares in Q4 2019, an estimated $7K.
Jacobi Capital Management first reported a position in Genomic Health, Inc. in Q2 2016 and held it in 14 quarters.
Jacobi Capital Management's Genomic Health, Inc. position peaked at $7K in Q3 2019.
0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.

Based on Jacobi Capital Management's 13F filing for Q4 2019, filed 3 Feb 2020.